Plasmid DNA Vaccine vector design: impact on efficacy, safety and upstream production

Por Williams, James A, Carnes, Aaron E, Hodgson, Clague P
Publicado em 2009

Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system

Por Luke, Jeremy, Carnes, Aaron E, Hodgson, Clague P, Williams, James A
Publicado em 2009

Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes

Por Williams, James A, Luke, Jeremy, Langtry, Sarah, Anderson, Sheryl, Hodgson, Clague P, Carnes, Aaron E
Publicado em 2009

Critical design criteria for minimal antibiotic-free plasmid vectors necessary to combine robust RNA Pol II and Pol III-mediated eukaryotic expression with high bacterial productio...

Por Carnes, Aaron E., Luke, Jeremy M., Vincent, Justin M., Anderson, Sheryl, Schukar, Angela, Hodgson, Clague P., Williams, James A.
Publicado em 2010

Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine

Por Luke, Jeremy M., Simon, Gregory G., Söderholm, Jonas, Errett, John S., August, J. Thomas, Gale, Michael, Hodgson, Clague P., Williams, James A.
Publicado em 2011